Effect of N-desulfated heparin on angiogenesis and vascular endothelial growth factor expression in mice with severe combined immunodeficiency

Jin-Lian Chen,Jin-Lai Lu,Ming-Xiang Chen,Wei-Xiong Chen,Jin-Shui Zhu,Ni-Wei Chen,Guo-Qiang Chen,Jian-Guo Geng
DOI: https://doi.org/10.3969/j.issn.1009-3079.2005.22.012
2005-01-01
Abstract:AIM: To investigate the effect of N-desulfated heparin on tumor metastasis, angiogenesis, and expression of vascular endothelial growth factor (VEGF) after ortho-topic implantation of human gastric carcinoma in mice with severe combined immunodeficiency (SCID). METHODS: The SCID mice metastasis model was established by in situ implantation of human gastric carcinoma tissue, then the mice were randomly divided into two groups: the normal saline group (treated with normal saline) and NNH group [treated with N-desulfated heparin, 10 mg/(kg·d) iv, 2/wk, for 3 wk]. The mice were sacrificed 6 wk after the implantation. The tumor metastasis, intratumoral microvessel density (MVD), and VEGF expression were evaluated respectively. RESULTS: The tumor metastasis rates were significantly different between normal saline and NNH group (80% vs 20%, P <0.05). No side effect such as hemorrhage was observed in the mice. The MVD was 8.0±3.1 in the normal saline group and 4.3±1.8 in the NNH group, and there was significant difference between those 2 groups (P <0.05). The positive rate of VEGF expression was significantly higher in the normal saline group than that in the NNH group (90% vs 20%, P <0.05). CONCLUSION: N-desulfated heparin can inhibit the metastasis of gastric cancer through inhibiting the expression of tumor VEGF and angiogenesis with no obvious side effect such as hemorrhage.
What problem does this paper attempt to address?